CD&R-backed Healogics Buys Accelecare from Revelstoke
March 04, 2015
Healogics, a portfolio company of Clayton, Dubilier & Rice, has acquired Accelecare Wound Centers from Revelstoke Capital Partners. Operating nearly 140 centers staffed with physicians, nurses and specialized technicians, Accelecare provides full-service wound care and disease management solutions to hospitals and related healthcare organizations across the U.S. Healogics, which was backed by CD&R just last year, is also a provider of wound care services, currently managing nearly 600 centers. Accelecare had been backed by Revelstoke since December 2013.